ASO Author Reflections: Limited Survival Benefit from Neoadjuvant Chemotherapy in ER+/HER2- Breast Cancer

Yutian Zou1, Lei Bian1, Hanqi Zhang1

  • 1Department of Breast Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.

Abstract

No abstract available in PubMed .

Related Concept Videos